We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDV icon
801
iShares International Select Dividend ETF
IDV
$8.61B
$1.57M 0.01%
40,550
+4,150
+11% +$156K
ESLT icon
802
Elbit Systems
ESLT
$34.3B
$1.56M 0.01%
+25,600
New +$1.51M
HALO icon
803
Halozyme
HALO
$12.1B
$1.56M 0.01%
122,706
+6,389
+5% +$94.8K
JWN
804
DELISTED
Nordstrom
JWN
$1.55M 0.01%
24,800
-5,892
-19% -$355K
OXFD
805
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.55M 0.01%
77,104
+2,104
+3% +$45.5K
ARGO
806
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$1.54M 0.01%
46,615
-1,670
-3% -$54.2K
SCG
807
DELISTED
Scana
SCG
$1.53M 0.01%
29,884
+2,740
+10% +$132K
LLTC
808
DELISTED
Linear Technology Corp
LLTC
$1.52M 0.01%
31,300
-580
-2% -$26.7K
CLGX
809
DELISTED
Corelogic, Inc.
CLGX
$1.52M 0.01%
50,700
+17,990
+55% +$592K
SNX icon
810
TD Synnex
SNX
$21B
$1.52M 0.01%
50,200
+1,800
+4% +$53.6K
AROC icon
811
Archrock
AROC
$5.36B
$1.52M 0.01%
34,600
AF
812
DELISTED
Astoria Financial Corporation
AF
$1.51M 0.01%
109,500
-12,900
-11% -$176K
THI
813
DELISTED
TIM HORTONS INC COM, CANADA
THI
$1.5M 0.01%
27,100
+1,700
+7% +$91.9K
MCO icon
814
Moody's
MCO
$80.9B
$1.5M 0.01%
18,887
-104,760
-85% -$8.2M
PH icon
815
Parker-Hannifin
PH
$117B
$1.5M 0.01%
12,500
-18,300
-59% -$2.2M
ISRG icon
816
Intuitive Surgical
ISRG
$133B
$1.49M 0.01%
30,600
-1,791
-6% -$84.4K
PENN icon
817
PENN Entertainment
PENN
$2.38B
$1.49M 0.01%
120,800
+78,727
+187% +$971K
TESO
818
DELISTED
Tesco Corp
TESO
$1.48M 0.01%
+80,000
New +$1.56M
LPT
819
DELISTED
Liberty Property Trust
LPT
$1.48M 0.01%
39,989
+9,000
+29% +$326K
ECPG icon
820
Encore Capital Group
ECPG
$2.1B
$1.47M 0.01%
32,200
-1,800
-5% -$86.9K
IBKR icon
821
Interactive Brokers
IBKR
$40.2B
$1.47M 0.01%
271,200
-9,200
-3% -$50.9K
ITGR icon
822
Integer Holdings
ITGR
$4.29B
$1.45M 0.01%
34,556
-1,097
-3% -$43.9K
BYD icon
823
Boyd Gaming
BYD
$5.53B
$1.44M 0.01%
109,300
-6,000
-5% -$69.5K
TTM
824
DELISTED
Tata Motors Limited
TTM
$1.43M 0.01%
+40,500
New +$1.28M
CRL icon
825
Charles River Laboratories
CRL
$13B
$1.43M 0.01%
23,700
-200
-0.8% -$11.7K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.